[Hormonal correction in combined therapy of temporomandibular joint dysfunction in women].

Abstract

Pain dysfunction syndrome of the temporomandibular joint (TMJ) in women is often accompanied by mammary and reproductive disorders associated with endocrine disturbances. 30 female patients aged 19-35 years suffering from of the pain dysfunction syndrome TMJ combined with intact dentition and orthognathic occlusion were studied. Dental examination was followed by gynecologic examination. According to the treatment the patients were divided into 2 groups. Group I included women who were administered conventional treatment (orthopedic treatment, drug and physiotherapy). In group II patients conventional therapy was also combined with monophase oral contraceptive "Femoden". Efficacy of treatment in group I was 46.67%; while group II patients showed a 100% favourable effect. Besides, combination of dental and gynecologic therapy was found to exert a 2.1 times more stable clinical effect us compared to conventional treatment. Hormone correction in women with reproductive pathology results in prolonged control of the pain dysfunction syndrome TMJ due to steroid normalization (hypothalamic, hypophysial, ovary steroid normalization) and has no side effects.

• Authors: Iu L Pisarevskiĭ, T E Belokrinitskaia, B S Khyshiktuev, V M Semeniuk, V S Kholmogorov
• Journal: Stomatologiia (Stomatologiia (Mosk)) Vol. 81 Issue 3 Pg. 33-8 ( 2002) ISSN: 0039-1735 [Print] Russia (Federation)
• Vernacular Title: Rol' gormonal'noĭ korrektsii v kompleksnom lechenii bolevogo sindroma disfunktsii visochno-nizhnecheliustnogo sustava u zhenshchin.
• PMID: 12224325 (Publication Type: Comparative Study, English Abstract, Journal Article)

Chemical References

• Contraceptives, Oral, Combined
• Contraceptives, Oral, Synthetic
• Norpregnenes
• Femovan
• Ethinyl Estradiol

Topics

• Adult
• Breast Diseases (complications)
• Combined Modality Therapy
• Contraceptives, Oral, Combined (therapeutic use)
• Contraceptives, Oral, Synthetic (therapeutic use)
• Ethinyl Estradiol (therapeutic use)
• Female
• Humans
• Norpregnenes (therapeutic use)
• Ovarian Diseases (complications)
• Temporomandibular Joint Dysfunction Syndrome (complications, drug therapy)
• Treatment Outcome